CLINICAL_TRIALS
trial_result
· 2023-09-05
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Summary
This Phase 2 study evaluated the safety and efficacy of bermekimab in patients with moderate to severe atopic dermatitis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Atopic Dermatitis, Eczema | Phase 2 | Status: COMPLETED | Results posted: 2023-09-05